Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 20 - Number 10

Review Article

The Roles of Alternative Splicing in Tumor-immune Cell Interactions

, 20(10): 729 - 740

Yue Wang, Honglei Zhang*, Baowei Jiao*, Jianyun Nie*, Xiyin Li, Wenhuan Wang and Hairui Wang


DOI: 10.2174/1568009620666200619123725



Review Article

Tumor-Induced Metabolism and T Cells Located in Tumor Environment

, 20(10): 741 - 756

Sara Iranparast, Sanaz Tayebi, Fatemeh Ahmadpour and Bahman Yousefi*


DOI: 10.2174/1568009620666200720010647



Review Article

Regulation of Breast Cancer Progression by Noncoding RNAs

, 20(10): 757 - 767

Ravishkumar L. Akshaya, Muthukumar Rohini and Nagarajan Selvamurugan*


DOI: 10.2174/1568009620666200712144103



Review Article

Targeting NUPR1 for Cancer Treatment: A Risky Endeavor

, 20(10): 768 - 778

Salma M.A. Mansour, Sahar A. Ali, Shaira Nofal and Sameh H. Soror*


DOI: 10.2174/1568009620666200703152523



Review Article

Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling

, 20(10): 779 - 788

Wujun Zou*, Xiaoyan Hu and Liang Jiang


DOI: 10.2174/1568009620999200730183631



Review Article


Systematic Review Article

Prognostic Value of MiRNAs in Patients with Laryngeal Cancer: A Systematic Review and Meta-Analysis

, 20(10): 802 - 810

Wujun Zou, Xiaoyan Hu, Dingting Wang and Liang Jiang*


DOI: 10.2174/1568009620666200806094709



Clinical Trial

Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL

, 20(10): 811 - 817

Sven Nilsson, Alexander Stein, Christian Rolfo, Anne L. Kranich, Julia Mann, Konstantinos Papadimitriou, Susann Theile, Stefanie Amberg and Carsten Bokemeyer*


DOI: 10.2174/1568009620666200628105727




Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog